We are a world-leading cancer research institute dedicated to improving patient lives through discovery science. 

We have built a truly collaborative culture, fostering connections between scientists, healthcare institutions and businesses to take our cancer research from bench to bedside.

Our state-of-the-art facilities and flexible core funding ensures our 300 scientists can deliver bold research programmes to accelerate progress for everyone. 

We are a department of the University of Cambridge, core-funded by Cancer Research UK. 

 

About us

Latest news

  • News

    Behind the Lab Coat: Dr Ania Piskorz, Head of Genomics

    Introducing Behind the Lab Coat, a new series by the Cancer Research UK Cambridge Institute! The series has two main aims: first, to help you to get to get to know the people who are doing amazing science at the Institute and, secondly, to introduce you to the breadth of “behind the scenes” roles required […]

    Find out more
  • News

    Maike de la Roche named Entrepreneurial Group Leader of the Year

    Dr Maike de la Roche has won the Entrepreneurial Group Leader of the Year category at the 2024 Cancer Research Horizons Innovation and Entrepreneurship Awards. The Innovation & Entrepreneurship Awards aim to celebrate researchers and innovators who are actively bridging the gap between oncology discoveries and positive patient outcomes. The Entrepreneurial Group Leader of the […]

    Find out more
  • News

    Novo Nordisk Prize 2024 honours pioneers of genome sequencing

    Prof Sir Shankar Balasubramanian, together with his co-inventor Prof Sir David Klenerman, have been awarded the 2024 Novo Nordisk Prize. The Novo Nordisk Prize recognises scientists who have provided outstanding international contributions to advance medical science to benefit people’s lives. The prize is awarded annually by the Novo Nordisk Foundation and is intended to further support […]

    Find out more
  • News

    Career Foundation Fellowships from Pancreatic Cancer UK awarded to two Institute postdocs

    Dr Shalini Rao and Dr Gianluca Mucciolo have each received fellowships from Pancreatic Cancer UK, together worth £550,000, to fund their research, which focuses on paving the way for new treatments and early detection of pancreatic cancer. The two new research projects, “Understanding the causes of tumour growth in early pancreatic cancer” and “Identifying new […]

    Find out more

Other Cancer Research UK funded Institutes